Background
==========

Caries is a multifactorial disease and our ongoing research continues to provide evidence that genetic factors related to the host are involved in caries susceptibility. Our previous studies focused on genetic variation of genes involved in the enamel formation \[[@B1]-[@B4]\] and in the immunological system \[[@B5]\]. We complemented these studies by performing a genome-wide linkage scan to unravel novel loci for caries \[[@B6]\].

The genome-wide linkage study identified three loci for low caries experience (5q13.3, 14q11.2, and Xq27.1) and two loci for high caries experience (13q31.1 and 14q24.3) \[[@B6]\]. The fine mapping of the locus 5q12.1-13.3 suggested that *BTF3* has a functional role in the pathogenesis of caries \[[@B7]\]. The fine mapping of the locus 14q11.2 pointed at *TRAV4* as involved in caries experience \[[@B8]\]. Both genes are suggested to be protecting factors against caries. These results clearly demonstrate that focusing on the regions identified by the genome-wide linkage analysis can lead to the identification of genetic contributors to caries. In the present study we fine mapped the locus 13q31.1 in order to identify genetic contributors involved in high caries experience.

Methods
=======

Studied population
------------------

We studied 3,151 individuals from six population data sets, including samples from the Philippines, USA, Brazil, and Turkey.

The Filipino sample set consisted of DNA samples from 477 subjects (224 females and 253 males) from 72 pedigrees recruited between 2005 and 2007 living in the Cebu Island. The mean age of the individuals was 25.8 years and ages ranged from one to 82 years. The mean DMFT/dmft score was 9.7 and scores ranged from 0 to 32. We compared individuals living in the same area in the Philippines, and therefore with similar cultural backgrounds and access to dental care, in an attempt to reduce the influence of environmental confounders. The families studied all come from the central part of the country, mostly Cebu Island, and the surrounding islands. All families are small-scale fishermen or landless rural dwellers. They all appear to be descendents from a proto-Malay stock. Most parents reported brushing the teeth of their children and similar dietary habits.

The sample from Pittsburgh, USA consisted of 1,481 (715 males and 766 females) unrelated subjects who sought treatment at the University of Pittsburgh and were part of the Dental Registry and DNA Repository project. The mean age of the individuals was 40.9 years and ages ranged from six to 92 years. The mean DMFT/dmft score was 15.9 and scores ranged from 0 to 28. This population is at high risk for oral and systemic diseases but no detailed data on caries risk factors are available for this study group. Pittsburgh is the largest city in the Appalachian region of the United States, which is one of the poorest in the country. Pittsburgh has had fluoridated water since 1953, however, nearly half of the children in Pittsburgh between six and eight have had cavities according to the State Department of Health of Pennsylvania (<http://www.portal.state.pa.us/portal/server.pt/community/oral_health/14180>). More than 70% of 15-year-olds in the city have had cavities, the highest percentage in the state. Close to 30% of the city's children have untreated cavities. That is more than double the state average of 14%.

From Brazil, two sample data sets were available for this study. The first consisted of DNA samples from 598 unrelated children and teenagers (313 males and 285 females) that sought treatment at the Federal University of Rio de Janeiro during 2010 and 2011. The mean age of the children was 9.0 years and ages ranged from two to 18 years. The mean DMFT/dmft score was 2.5 and scores ranged from 0 to 17. The second sample set included DNA samples of children from Nova Friburgo recruited during the year of 2012. The city of Nova Friburgo is located in the northern mountainous region of the Rio de Janeiro state, 136 km from downtown Rio de Janeiro. Children (N =  320, 158 males and 162 females) were from eight daycare centers in Nova Friburgo. The mean age of the children was three and half years and ages ranged from one to six years. The mean dmft score was 1.4 and scores ranged from 0 to 16. Variables related to risk factors for caries were not available for all participants and these two Brazilian cohorts and these data could not be included in the analyses.

From Istanbul, Turkey, two sample data sets were also available for this study. The first sample was from a study originally designed as a case--control study and consisted of 172 unrelated children (93 females and 79 males) from three to six years of age recruited during the year of 2006. Ninety children had a dmft score of four or more and 82 children were caries free \[[@B2]\]. The second sample was designed as a cohort study and included 103 children (45 males and 58 females). The mean age of the children was five years and ages ranged from four to six years. The mean dmft score was 2.5 and scores ranged from 0 to 9. For this study group, most parents reported not brushing the teeth of their children. Drinking water in the region is not artificially fluoridated.

These samples were used with the approval of the University of Pittsburgh Institutional Review Board and each Institutional Review Board at the original sites where the samples were obtained (H.O.P.E. Foundation International Institutional Review Board, the Philippines; Federal University of Rio de Janeiro University Hospitals Research Ethics Committee, Rio de Janeiro, Brazil; Federal Fluminense University Research Ethics Committee, Nova Friburgo Brazil, and Istanbul University Institutional Review Board, Turkey) and appropriate informed consent was obtained from all participants. Age appropriate assent documents were used for children between seven and 14 years and informed; written consent was obtained from the child, as well as from the parents.

Determination of caries experience
----------------------------------

Caries was diagnosed using a modified World Health Organization protocol recommended for oral health surveys \[[@B9]\]. Teeth lost to trauma or primary teeth lost to exfoliation were not included in the final DMFT/dmft scores. When records indicated that teeth were extracted for orthodontic reasons or periodontal disease, or treatments were performed in sound teeth, these situations were not included in the final DMFT/dmft scores. The studies developed in Turkey included white spot lesions as evidence of caries. For all studies, carious lesions were recorded as present when a break in enamel was apparent on visual inspection. All the examiners carried out the clinical examination after being calibrated by an experienced specialist. Details about the determination of caries experience were previously described \[[@B1],[@B2],[@B4],[@B6]\].

In this study, the populations were classified as either \'low caries experience' or \'high caries experience', based on DMFT/dmft distribution in each cohort (DMFT/dmft mean and standard deviation) and subject's age. The criteria used here for classification of caries experience took age into consideration, since it is expected that caries experience will increase in the general population with age \[[@B10]\]. Table [1](#T1){ref-type="table"} presents caries experience definitions for Filipinos and US cohorts. For the Turkish and Brazilian cohorts (which included only children), subjects that had a DMFT/dmft score between 0--2 were classified as \'low caries experience.' The subjects that had a DMFT/dmft score 3 or higher were classified as \'high caries experience.'

###### 

Definitions of caries experience based on age and DMFT/dmft scores used in the Filipino, US, and Argentina data sets

               **Philippines**                                                                                         **USA**                     **Argentina**  
  ------------------------------------------ ------------------------------------------------------ --------------------------------------------- --------------- -------------
           Caries Experience Level                                 DMFT/dmft                                   Caries Experience Level               DMFT/dmft    
    Children \[under to 12 years of age\]     Children and teenagers \[from 6 to 19 years of age\]                                                                
            Low caries experience                                     0-3                                                 0                                       
            Low caries experience                                     0-2                                      High caries experience               4 or higher    1 or higher
            High caries experience                                3 or higher                        Young Adults \[from 20 to 39 years of age\]                  
   Teenagers \[from 13 to 19 years of age\]                  Low caries experience                                      0-10                            0-2       
            High caries experience                                11 or higher                                       3 or higher                                  
            Low caries experience                                     0-5                             Middle age \[from 40 to 59 years of age\]                   
            High caries experience                                6 or higher                                   Low caries experience                  0-15            0-5
     Adults \[20 years of age and older\]                    High caries experience                                 16 or higher                    6 or higher   
    Elderly \[60 years of age and older\]                                                                                                                         
            Low caries experience                                     0-8                                       Low caries experience                  0-20            0-8
            High caries experience                                8 or higher                                  High caries experience              21 or higher    9 or higher

Single Nucleotide Polymorphism (SNP) genotyping
-----------------------------------------------

A target region at the locus 13q31.1 was fine mapped based on our previous genome-wide linkage results \[[@B6]\]. This region covers approximately one million base pairs. For the selection of the SNPs we used data from the International HapMap Project on Whites and Chinese (<http://www.hapmap.org>), viewed through the software Haploview \[[@B11]\]. Based on pairwise linkage disequilibrium and haplotype blocks we selected 61 SNPs (Table [2](#T2){ref-type="table"}) in the region and genotype was performed by polymerase chain-reactions with the Taqman method with the real-time PCR system ABI PRISM® 7900HT Sequence Detection System (Foster City, CA, USA). Probes were supplied by Applied Biosystems (Foster City, CA, USA).

###### 

Single nucleotide polymorphisms (SNPs) and summary p-values of the association studies in the Philippines

   **Marker ID**   **SNP**   **Minor allele frequency**    **p-value**    **Base pair position**
  --------------- --------- ---------------------------- --------------- ------------------------
     rs6563245     **CT**              0.271              **0.0000350**       chr13:82213394
     rs4432145     **CT**              0.448                0.3542140         chr13:82225148
     rs9545827     **AG**              0.194                0.0634870         chr13:82239682
    rs17074565     **CG**              0.119              **0.0009550**       chr13:82242712
     rs9531237     **AG**              0.375                0.4240030         chr13:82262814
     rs9601669     **CT**              0.151              **0.0000140**       chr13:82267631
     rs9545836     **AG**              0.189                0.0071440         chr13:82273953
     rs2151504     **AC**              0.241                0.1266300         chr13:82291577
     rs9318796     **CT**              0.298                0.0768220         chr13:82300870
     rs9545841     **AG**              0.353                0.3168520         chr13:82309728
     rs9531243     **AT**              0.461                0.4311590         chr13:82315374
     rs7987364     **CT**              0.275                0.0997340         chr13:82320094
     rs1490023     **CT**              0.012              **0.0008920**       chr13:82336749
     rs9601697     **AG**              0.152                0.0218540         chr13:82350782
    rs12429667     **CT**              0.206                0.0037260         chr13:82365765
     rs9318803     **CT**              0.078              **0.0000045**       chr13:82390255
     rs1565397     **CT**              0.008                0.0183477         chr13:82410045
     rs9545880     **CT**              0.214                0.1434080         chr13:82413369
     rs7987529     **CT**              0.472                0.3716050         chr13:82417111
     rs9318814     **AG**              0.383                0.0059570         chr13:82451368
     rs9545908     **AG**              0.375                0.7773880         chr13:82453046
     rs9574982     **CT**              0.264                0.1193090         chr13:82467023
     rs4112704     **AT**              0.140                0.0717210         chr13:82480825
     rs7336983     **AG**              0.187                0.1013090         chr13:82485714
     rs9601766     **CT**              0.128                0.0461800         chr13:82494257
     rs9545915     **AC**              0.278                0.3908930         chr13:82498426
     rs9593627     **GT**              0.331                0.0233040         chr13:82518251
    rs17074923     **AC**              0.233              **0.0000619**       chr13:82518481
     rs1280005     **CT**              0.026                0.0013520         chr13:82561205
     rs1497062     **AT**              0.341                0.0831310         chr13:82581442
     rs9531282     **AG**              0.001                0.0311380         chr13:82582150
     rs2036130     **AG**              0.133              **0.0009210**       chr13:82606614
     rs1331583     **CT**              0.313                0.0566020         chr13:82692849
     rs9318840     **GT**              0.304                0.0566020         chr13:82770704
     rs980635      **AC**              0.077              **0.0001120**       chr13:82869193
     rs4497555     **AG**              0.400                0.0702320         chr13:82893029
     rs9575086     **AG**              0.350                0.0035460         chr13:82913268
     rs945359      **CT**              0.343                0.0020910         chr13:82946589
     rs9546151     **AG**              0.004                0.3173110         chr13:83083854
     rs9318882     **AC**              0.469                0.1216210         chr13:83127811
     rs7322057     **AG**              0.263              **0.0000003**       chr13:83155775
     rs1333586     **AC**              0.125                0.0122800         chr13:83183607
    rs12869343     **GT**              0.294                0.0014180         chr13:83183712
    rs12429646     **AG**              0.210                0.0191480         chr13:83207138
     rs7990715     **AG**              0.473                0.0437580         chr13:83208055
     rs9531374     **AG**              0.397                0.6243800         chr13:83212401
    rs12429573     **AG**              0.252                0.0192650         chr13:83222937
     rs2840279     **AG**              0.368                0.3640430         chr13:83230001
     rs7990920     **AG**              0.339                0.1372060         chr13:83243050
     rs9601950     **CT**              0.483                0.4572350         chr13:83268220
     rs9546224     **AT**              0.314                0.1523830         chr13:83285405
    rs12874183     **AT**              0.014                0.0253470         chr13:83293568
     rs9593705     **CT**              0.170                0.0041870         chr13:83294037
     rs7319120     **CT**              0.400                0.1160700         chr13:83314434
     rs7999400     **AG**              0.311                0.0441200         chr13:83322249
     rs9601986     **AT**              0.201              **0.0000260**       chr13:83401098
     rs4885849     **CT**              0.085              **0.0000190**       chr13:83414814
     rs9565817     **AG**              0.304                0.1260220         chr13:83423770
     rs7983443     **CT**              0.436                0.6538970         chr13:83430208
     rs982568      **CT**              0.429                0.4828760         chr13:83438876
    rs11617124     **AC**              0.251                0.0877580         chr13:83443386
     rs1906326     **AG**              0.491                0.0210680         chr13:83451878

Note: Bolded number indicates a statistically significant value.

For the first step of the genotype analyses, we evaluated the 61 selected SNPs in the Filipino families. The association between caries experience and the SNPs were tested with the transmission disequilibrium test (TDT) within the programs Family-Based Association Test (FBAT) under a recessive model \[[@B12]\], since the original linkage results \[[@B6]\] suggested a recessive model. After Bonferroni correction (0.05/61), an established alpha was 0.00082, to accommodate for the concern of multiple tests. In the second step of the genotyping analyses, we follow-up the results of eleven SNPs selected from the original 61 SNP panel based on obtained p-values. The data sets from the US, Brazil, and Turkey were tested. The differences in genotype and allele frequencies between \'high' and \'low' caries experience groups were tested using PLINK with an established alpha of 0.05. Haplotype analysis was also performed. Hardy-Weinberg equilibrium was evaluated using the chi-square test within each SNP in each population and only the results that were in Hardy-Weinberg equilibrium were further analyzed.

Bioinformatics analysis to predict transcription factor binding sites
---------------------------------------------------------------------

Since the 13q.31.1 region studied contains no genes, sequences containing the eleven associated SNPs were analyzed with AliBaba 2.1 software (<http://www.generegulation.com/pub/programs/alibaba2/index.html>).

This analysis was performed for the identification of an alteration of the prediction of potential transcription factor binding sites according to the base change of each SNP.

Gene expression analyses
------------------------

DNA and RNA extracted from whole saliva were used to assess expression levels of genes selected from the bioinformatics analysis. These samples came from 143 unrelated individuals living in twelve sites of the Patagonian region of Argentina recruited for two weeks, one during the month of December 2006 and the other during the month of May 2008, and are detailed elsewhere \[[@B7],[@B8]\]. Samples are part of the University of Pittsburgh Center for Craniofacial and Dental Genetics studies. The mean age of the subjects was 21.7 years (between 1 and 72 years) and both the Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC) and University of Pittsburgh Institutional Review Boards approved the study of these samples and appropriate written informed consent was obtained from all participants (parents provided consent for the participation of individuals 17 years of age and under). The criteria used for classification of caries experience are presented in Table [1](#T1){ref-type="table"}.

Quantitative real-time PCR was used to determine expression in whole saliva of *GATA1*, *GR*, *GATA3*, *IL4*, *IL5*, and *IL13* genes (Table [3](#T3){ref-type="table"}). *GATA1*, *GR*, and *GATA3* were selected because they are predicted to bind in the sequence affected by the SNP rs17074565. *IL4*, *IL5*, and *IL13* were selected due to evidence that *GATA3* can promote secretion of these genes \[[@B13]\].

###### 

Primers used for mutation search and gene expression analyses

                        **Primers used for mutation search**                                                                                                                                                               
  -------------------------------------------------------------------------------- ---------------------------- ------------------------------------ --------------------------------------------------------------------- ------------------------------------------------------------------------------------------------
                                                                                                                                                                                                                                                                           
                                      Forward                                          CAGCTTTATCGCCAGAGTCC                     350                   94°C 5 min→ 35×\[94°C 30 sec, 56°C 30 sec, 72°C 30 sec\]→72°C 5 min  
                                      Reverse                                          CCTCTTCCTCACCATCACCT                                                                                                                
                                      Forward                                          AAGAAGGTGGGGAGGAAGAG                     550                   94°C 5 min→ 35×\[94°C 30 sec, 53°C 30 sec, 72°C 30 sec\]→72°C 5 min  
                                      Reverse                                         GGTCATCCGAGATCATTAAAAA                                                                                                               
                                      Forward                                       TTTTTATACATATTGTTAGGGTCAGC                  500                   94°C 5 min→ 35×\[94°C 30 sec, 53°C 30 sec, 72°C 30 sec\]→72°C 5 min  
                                      Reverse                                       CAGTTTGTTTACCATCTCAAACACTT                                                                                                             
   **Primers used for quantitative real-time polymerase chain reaction analysis**                                                                                                                                          
                                  **Target Gene**                                           **Primer**             **Primer sequences (5′--3′)**                               **Amplicon size**                                                            **Thermal cycling condition**
                                                                                                                                                                               **(base pairs)**                                                                            
                                      *GATA1*                                                Forward                    TACTCAGTGCACCAACTGCC                                          114                                   50°C 2 min, 95°C 10 min→ 40×\[95°C 15 sec, 60°C 1 min\]→ 95°C 15 sec, 60°C 30 sec, 95°C 15 sec
                                      Reverse                                          CGGTTCACCTGGTGTAGCTT                                                                                                                
                                        *GR*                                                 Forward                    AAGGGTTTGCTTTCACCCCA                                          138                                  
                                      Reverse                                          AAGCGTGTTGCAATTTCCCC                                                                                                                
                                      *GATA3*                                                Forward                    GAGATGGCACGGGACACTAC                                          102                                  
                                      Reverse                                          CTGCAGACAGCCTTCGCTT                                                                                                                 
                                       *IL4*                                                 Forward                    TCTTCCTGCTAGCATGTGCC                                          113                                  
                                      Reverse                                          GGTGCACAGAGTCTTCTGCT                                                                                                                
                                       *IL5*                                                 Forward                   AGCCAATGAGACTCTGAGGAT                                          116                                  
                                      Reverse                                          CAGTACCCCCTTGCACAGTT                                                                                                                
                                       *IL13*                                                Forward                    ATGCATCCGCTCCTCAATCC                                          78                                   
                                      Reverse                                          AGTGAGAGCATGACCGTGG                                                                                                                 
                                      *GAPDH*                                                Forward             [ACCACAGTCCATGCCATCAC]{.smallcaps}                                   452                                  
                                                                                             Reverse             [TCCACCACCCTGTTGCTGTA]{.smallcaps}                                                                        

Parametric and nonparametric tests were used to compare differences in expression between high and low caries experience individuals. The Pearson or Spearman correlation tests were used to analyze the strength of the relationship between *GATA3* and interleukins (*IL4*, *IL5*, and *IL13*) to verify if there is evidence of co-expression of *GATA3* and interleukins in whole saliva.

Mutation analysis
-----------------

We sequenced a region in 13q31.1 that is a highly conserved (Figure [1](#F1){ref-type="fig"}). This highly conserved area was identified by evaluation of data available at the UCSC genome browser (<http://genome.ucsc.edu/>). Three primers for the amplification of the entire region of approximately 1,200 base pairs were designed using the software PRIMER3. Primer sequences and PCR conditions are presented in Table [3](#T3){ref-type="table"}. The sequences obtained were verified against a consensus sequence obtained from the UCSC genome browser with the software Sequencher 5.1.

![**Identification of a highly conserved sequence in 13q31.1.** Legend: **A**- Region in the chromosome 13 screened for a highly conserved sequence. **B**- The graph shows the level of nucleotide conservation across mammals, in which higher bars indicates higher conservation. **C**- Detail of the highest conserved region (data from the UCSC Genome Browser Feb. 2009 (GRCh37/hg19) assembly: <http://genome.ucsc.edu>).](1471-2350-14-116-1){#F1}

Results
=======

Association results in the Filipino Families
--------------------------------------------

Out of 61 SNPs used for fine mapping the target chromosomal region, eleven were statistically significant or borderline associated (p ≤ 0.001) with caries experience. These results are summarized in the Table [4](#T4){ref-type="table"}. Associations could also be seen between caries experience and the haplotypes of these markers (Table [5](#T5){ref-type="table"}).

###### 

Summary results of the associated markers according Family-Based Association Test (FBAT) in the Filipino families

   **Marker ID**   **SNP\***   **MAF**^**\#**^   **p-value**    **Position**
  --------------- ----------- ----------------- ------------- ----------------
     rs6563245        CT            0.271         0.0000350    chr13:82213394
    rs17074565        CG            0.119         0.0009550    chr13:82242712
     rs9601669        CT            0.151         0.0000140    chr13:82267631
     rs1490023        CT            0.012         0.0008920    chr13:82336749
     rs9318803        CT            0.078         0.0000045    chr13:82390255
    rs17074923        AC            0.233         0.0000619    chr13:82518481
     rs2036130        AG            0.133         0.0009210    chr13:82606614
     rs980635         AC            0.077         0.0001120    chr13:82869193
     rs7322057        AG            0.263         0.0000003    chr13:83155775
     rs9601986        AT            0.201         0.0000260    chr13:83401098
     rs4885849        CT            0.085         0.0000190    chr13:83414814

\*Base change; ^\#^Minor allele frequency.

###### 

Summary results of the haplotype analyses in the 72 Filipino families

  **Haplotype**                      **n**   **Alleles**   **p-value**
  --------------------------------- ------- ------------- -------------
  rs636245-rs17074565                  7         T-G         0.00505
  rs17074565- rs9601669               10         G-C         0.00016
  rs9601669-rs1490023                 29         C-C         0.00001
  rs1490023-rs9318803                  8         C-C         0.00060
  rs9318803-rs17074923                 7         C-A         0.01201
  rs17074923-rs2036130                16         A-A         0.00006
  rs2036130-rs980635                  17         A-C         0.00002
  rs980635-rs7322057                  14         G-C        \<0.00001
  rs9601986-rs4885849                 24         A-C        \<0.00001
  rs17074565- rs9601669-rs1490023     18        C-C-C        0.00058
  rs17074923-rs2036130-rs980635       12        A-A-C        0.00011

Notes: n = number of informative families.

Association results in the follow-up Populations
------------------------------------------------

Follow-up studies showed significant association for the markers rs17074565 and rs980635 in the Brazilian data set from Nova Friburgo and additional borderline results, which are presented in Table [6](#T6){ref-type="table"}. A borderline result was found for the marker rs9601986 in a recessive model (p = 0.06) in the population data set from the US. In this same population, the genotype TT of the marker rs4885849 demonstrated to be a protect factor against caries in the logistic regression model (p = 0.029; OR = 0.26, 95% confidence interval 0.07-0.87). The logistic regression analysis included genotypes of the eleven markers selected after the analyses with the Filipinos as covariates.

###### 

Summary results of the follow-up studies

   **Markers**   **Pittsburgh (USA)**   **Rio de Janeiro (Brazil)**   **Nova Friburgo (Brazil)**   **Istanbul (Turkey)**   **Istanbul (Turkey)**                                         
  ------------- ---------------------- ----------------------------- ---------------------------- ----------------------- ----------------------- ------------- ------ ---------- ------ ------
    rs6563245            0.49                      0.58                           \-                        \-                   **0.07**             0.21       0.30     0.17     0.75   0.73
   rs17074565            0.32                      0.56                          0.98                      0.98                    0.68            **0.05\***    0.48     0.18      \-     \-
    rs9601669            0.70                      0.92                          0.96                      0.79                    0.56               0.78       0.79     0.23     0.14   0.12
    rs1490023            0.58                      0.33                          0.83                      0.60                    0.15               0.20       0.11     0.23      \-     \-
    rs9318803            0.93                      0.96                        **0.06**                    0.16                    0.61               0.62       0.22   **0.06**   0.40   0.35
   rs17074923            0.46                      0.62                          0.44                      0.37                     \-                 \-        0.50   **0.07**    \-     \-
    rs2036130             \-                        \-                           0.16                      0.44                    0.66               0.82       0.41     0.51     0.72   0.69
    rs980635              \-                        \-                           0.80                      0.91                    0.33            **0 .03\***   0.85     0.65     0.72   0.75
    rs7322057            0.94                      0.95                          0.20                      0.08                     \-                 \-         \-       \-      0.15   0.25
    rs9601986            0.13                      0.16                          0.66                      0.82                    0.98               0.82       0.90     0.55     0.47   0.73
    rs4885849            0.26                      0.29                          0.31                      0.59                    0.55               0.17       0.39     0.33     0.93   0.62

Note: \*indicates p ≤ 0.05; bold font indicates borderline results.

In the case--control study from Turkey, the marker rs9318803 was a protect factor for caries experience (p = 0.02; OR = 0.37, 95% confidence interval 0.16-0.85) in the logistic regression. An association with this same marker is the same population data set was also observed when the recessive model was tested (p = 0.03).

Transcription factor binding site predictions according to the base change in each SNP
--------------------------------------------------------------------------------------

We determined potential transcription factors binding sites according to the base change of each associated SNP in the DNA sequence. Three of the eleven SNPs (rs17074565, rs9601669, and rs4885849) were predicted to alter the transcription factors binding to the sequence (Table [7](#T7){ref-type="table"}). Prediction change for SNP rs17074565 were of particular interest. When the sequence has the C allele the predicted transcription factors binding are *GR* (glucocorticoid receptor) and *GATA1* (GATA binding protein 1). When the allele G is present, the predicted transcription factor binding is *GATA3* (GATA binding protein 3).

###### 

Predicted transcription factor binding sites according to the base change

  **rs number**                                                            **rs17074565**
  --------------------------------------- -------------------------------- --------------------------------
  **Flanking Sequence and base change**    cctggcagacaaa**C**agataatcattt  cctggcagacaaa**G**agataatcattt
  ====NF-1==                                         ====NF-1==            
  =====GR===                                         ===GATA-3=            
  ====GATA-1===                                                            
  **Potential transcription factors**                                      
  **rs number**                                    **rs9601669**            
  **Flanking Sequence and base change**          aggtgtaa**C**gagag        aggtgtaa**T**gagag
  ===Oct-1==                                                               
  **Potential transcription factors**                                      
  **rs number**                                    **rs4885849**            
  **Flanking Sequence and base change**      tctctttgact**C**tccttccata    tctctttgact**T**tccttccata
                                                     ====CPC1==            =REV-ErbA=
                                                                           ===c-Rel==
  **Potential transcription factors**                                      ===LyF-1==

Note: Upper cases bold indicates base change.

Gene expression in Whole Saliva
-------------------------------

The genotype distribution of the SNP rs17074565 in the tested samples was 84 CC, 4 CG, and 10 GG. There was no association between caries experience and genotype distribution.

In the real-time PCR analysis, mRNA expression comparisons were performed between low and high caries experience groups, and according to genotypes. Statistically significant difference in the expression level of *GR* was found between low caries and high caries experience individuals (Table [8](#T8){ref-type="table"}). No differences were found when genotypes and gene expression levels were compared between individuals with low and high caries experience (Table [9](#T9){ref-type="table"}).

###### 

Summary results of gene expression levels in whole saliva between individuals with low and high caries expression

   **Gene**   **Tested groups**                                                                                             
  ---------- ------------------- ---------------- ---- ---------------- ----------- ---- --------------- ---- ------------- -------
   *GATA1*           15           740.4 ± 653.7    20   515.3 ± 256.2      0.731     33   663.9 ± 346.8   5    22.6 ± 15.2   0.523
     *GR*            41            41.1 ± 28.1     61     35.8 ± 9.1     **0.046**   80    76.8 ± 21.1    15    0.8 ± 4.6    0.448
   *GATA3*           45            11.1 ± 37.5     70    27.1 ± 95.1       0.286     90   38.3 ± 150.1    17    3.4 ± 6.3    0.341
    *IL4*            45           621.3 ± 3175.5   70   962.3 ± 5931.5     0.996     90   14.91 ± 75.9    17   1.9 ± 45.3    0.483
    *IL5*            36           179.6 ± 779.3    52   2956.5 ± 16035     0.303     68   753.5 ± 641.3   11   25.1 ± 15.6   0.705
    *IL13*           16           740.4 ± 2614.8   20   515.3 ± 1145.6     0.731     33   72.7 ± 220.1    5     0.9 ± 1.8    0.323

Note: bold form indicates p \< 0.05.

###### 

Comparison of gene expression levels depending on genotypes between individuals with low and high caries experience

   **Gene expression**   **n**        **CC**         **n**    **CG + GG**    **P-value**
  --------------------- ------- ------------------- ------- --------------- -------------
          *GR*                                                              
        Low Caries        30        1.36 ± 6.2         6      0.16 ± 0.15       0.357
        High caries       17        0.13 ± 0.72        7     0.90 ± 60.07   
         *GATA1*                                                            
        Low Caries        14     839.53 ± 2793.54      2      1.68 ± 0.64       0.412
        High caries       17     595.01 ± 1229.78     \-          \-        
         *GATA3*                                                            
        Low Caries        33       13.48 ± 43.56       7      4.67 ± 8.07       0.601
        High caries       50      33.17 ± 110.33       7      2.66 ± 5.82   
          *IL4*                                                                    
        Low Caries        33       12.17 ± 17.55       7     4.21 ± 10.48       0.910
        High caries       50       18.07 ± 90.92       7      0.37 ± 0.58   
          *IL5*                                                                    
        Low Caries        27       207.1 ± 893.2       5     35.19 ± 75.47      0.839
        High caries       36     1254.67 ± 7236.54     5     19.57 ± 25.98  
         *IL13*                                                                    
        Low Caries        14      84.29 ± 299.01       2      0.21 ± 0.09       0.886
        High caries       17      70.04 ± 154.01      \-          \-               

*GATA3* expression was statistically significant correlated with *IL4* expression (r = 0.46; p \< 0.0001), *IL5* expression (r = 0.23; p = 0.019), and *IL13* expression (r = 0.66; p \< 0.0001).

Mutation analysis
-----------------

For mutation analyses, we selected 33 unrelated individuals from the Philippines that carried two copies of the associated alleles of markers rs6563245, rs17074565, rs9601669, rs1490023, and rs9318803. These markers were selected due to the proximity with the highly conserved region identified in the multispecies comparison (Figure [1](#F1){ref-type="fig"}). No mutations were found.

Discussion
==========

Our previous genome-wide linkage analysis showed suggestive linkage (LOD score above 2.0) to 13q31.1 when high caries experience was tested under a recessive model \[[@B6]\]. Our fine-mapping studies in the expanded data set of Filipino families confirmed the initial linkage results and showed association with markers in the locus. Eleven markers were over represented in allele transmissions to individuals with high caries experience. Follow-up studies of these eleven markers in five independent population data sets showed trends for association and associations between a subset of these markers in 13q31.1 and high caries experience. One possible explanation for the different results found in the Filipino samples in comparison to the other data sets is the possibility that the population from the Philippines studied here was more homogeneous, with very limited access to dental care, very similar diets based on rice and corn, and no exposure to fluorides and similar oral hygiene habits.

Since there are no genes in the studied region identified originally in our genome-wide linkage analysis, one of the intergenic SNPs in the region could in fact contribute to high caries experience. Another possibility is that the associated SNPs in the region could be in linkage disequilibrium to genetic variants outside the studied region, since the extent of linkage disequilibrium in the human genome can be greater than 100 kilobases \[[@B14]-[@B16]\].

One mechanism we are proposing is that the locus 13q31.1 may influence caries by altering transcription efficiency. The genetic variant (SNP) associated with high caries experience may disrupt a transcription factor-binding site. It is common knowledge that transcription-factors bind directly to DNA to cause changes in gene expression. To gain insight in this hypothesis we predicted transcription factors that bind to the sites of the SNPs associated with caries experience. Our analyses suggested that three markers (rs17074565, rs9601669, and rs4885849) potentially alter the prediction of the transcription factors binding to the region depending on the base change. Genes such as *OCT1* (organic caution transporters), *CPC1* (central pair complex 1), *c-Rel* (reticuloendotheliosis viral oncogene homolog), and *LyF-1* (IKAROS family zinc finger 1) were predicted to bind at the sequences of certain SNPs depending on the base change. The genes most likely to be involved in the pathogenesis of caries based on their function were related to the predictions made using the base change of SNP rs17074565. The C allele was predicted to have *GR* (glucocorticoid receptor) and *GATA1* (GATA binding protein 1) binding, but this prediction changed to *GATA3* (GATA binding protein 3) when the G allele was input. GR is the receptor to which glucocorticoids bind and there is evidence that show the use of anti-asthmatic medications with glucocorticoids decrease salivary flow rate and changes saliva composition and saliva pH \[[@B15]-[@B23]\]. In addition, rats receiving continuous glucocorticoid infusion show significantly increased caries progression, which may mean that glucocorticoids reduce the response of odontoblasts in the presence of a carious lesion. Our expression data show a statistically significant difference in *GR* expression when individuals with low and high caries experience were compared. The use of glucocorticoids to treat asthma is a likely mechanism that explains at least in part the evidence suggesting individuals with asthma have higher caries experience \[[@B24]\], however we have no record of our study samples came from individuals being treated with glucocorticoids. One possible reason we detected differential *GR* expression with higher levels in individuals with lower caries experience relates to individual salivary cortisol levels. Cortisol provides a quick burst of energy for survival purposes, heighten memory functions, burst immunity, lower sensitivity to pain, and helps maintain homeostasis. When secreted a higher levels for longer periods of time, it relates to a state of chronic stress. Salivary cortisol levels are found to be elevated in children with rampant caries and those levels will decrease after restorative treatment is provided \[[@B25]\]. Furthermore, children with early childhood caries have significantly higher levels of salivary cortisol when compared to caries free children, and a positive correlation of salivary cortisol levels of the mothers of children affected by early childhood caries exist \[[@B26]\], suggesting both child and mother salivary cortisol level may impact incidence of early childhood caries. Higher expression of *GR* in whole saliva of individuals with lower caries experience in our data may indicate these individuals have lower levels of stress, but also this may indicate a more active immune response system. Conversely, individuals with higher caries experience showing lower levels of *GR* expression in whole saliva may be more susceptible to cariogenic biofilm formation.

Our study has the obvious limitation of sample sizes that might not allow for the detection of relatively small effects. The frequency of the G allele of rs17074565 in the Argentina dataset is 12% and comparisons of relative gene expression stratified by genotypes were likely impaired in our data. However, our data also showed a correlation between *GATA3* levels of expression in whole saliva and expression of *IL4*, *IL5*, and *IL13* in the same individuals, which confirms previous findings \[[@B27]\]. Although the expression of these genes in whole saliva was not different depending on the caries experience in our data, it is possible that these genes may be involved in the pathogenesis of caries by the modulation of immune responses.

Another limitation is differences in caries definitions from the multiple study samples. The Turkish case--control cohort included white spot lesion as evidence of caries, while the other populations had carious lesions recorded as present when a break in enamel was apparent on visual inspection. Different definitions are due to the individual study designs that included examinations in a dental office versus in the house of the family participants, or the possibility of using compressed air to dry teeth. These differences can impact our results, particularly for the cohorts with lower caries levels (*i.e.*, from Brazil). One area of active research in our group is the determination of the best definition of caries for genetic analyses. The distribution of caries in the study population was different and we scaled low and high caries experience differently to accommodate those distinctions; hence, the different definitions in Table [1](#T1){ref-type="table"}. The average caries experience level (mean DMFT scores) was used to help guide the determination of caries experience by age in each group.

Conclusions
===========

Genetic factors that contribute to high caries experience may exist in the gene desert 13q31.1 studied. rs17074565 may have a functional role in caries, disrupting the binding site for two different transcription factors that might be involved with immune responses. *GR* expression in saliva and salivary cortisol may be biomarkers for caries risk and should be further explored.
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